AgeX Therapeutics (STU:0X40) 3-Year EBITDA Growth Rate : -238.10% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is AgeX Therapeutics 3-Year EBITDA Growth Rate?

AgeX Therapeutics's EBITDA per Share for the three months ended in Dec. 2023 was €-2.93.

During the past 3 years, the average EBITDA Per Share Growth Rate was -238.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -109.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of AgeX Therapeutics was 14.10% per year. The lowest was -238.10% per year. And the median was -88.65% per year.

Competitive Comparison of AgeX Therapeutics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, AgeX Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AgeX Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AgeX Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where AgeX Therapeutics's 3-Year EBITDA Growth Rate falls into.

AgeX Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

AgeX Therapeutics (STU:0X40) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

AgeX Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of AgeX Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

AgeX Therapeutics (STU:0X40) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AgeX Therapeutics Inc (STU:0X40) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1101 Marina Village Parkway, Suite 201, Alameda, CA, USA, 94501

Website

https://www.agexinc.com

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

AgeX Therapeutics (STU:0X40) Headlines

No Headlines